Opportunity Information: Apply for CDC RFA GH11 1154SUPP16
Apply for CDC RFA GH11 1154SUPP16
- The HHS-CDC in the health sector is offering a public funding opportunity titled "Support for Strengthening and Expanding HIV/AIDS Surveillance Activities in South Africa under PEPFAR" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067.
- This funding opportunity was created on Jan 08, 2016 and posted on Jan 08, 2016.
- Applicants must submit their applications by Mar 08, 2016. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The grant opportunity titled "Support for Strengthening and Expanding HIV/AIDS Surveillance Activities in South Africa under PEPFAR" (Funding Opportunity Number CDC RFA GH11-1154SUPP16) is a U.S. government discretionary funding announcement issued by the U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (HHS-CDC). The funding instrument is a cooperative agreement, which typically means CDC expects to have substantial involvement in the work alongside the recipient rather than simply issuing funds and stepping back. The program falls under the health funding activity category and is associated with CFDA 93.067. The opportunity was posted and created on January 8, 2016, with an application closing date of March 8, 2016. The notice indicates an expectation of one award, and the award ceiling is listed as 0, suggesting the ceiling was either not specified in the public summary or would be defined through budget negotiation and the cooperative agreement terms rather than a fixed cap shown in the synopsis.
This announcement is designed to fund implementation of the DREAMS initiative, a major HIV prevention effort focused on adolescent girls and young women ages 15 to 24. DREAMS stands for Determined, Resilient, Empowered, AIDS-free, Mentored, and Safe. The initiative was launched through a partnership formed in 2015 among PEPFAR, the Bill and Melinda Gates Foundation, and the Nike Foundation, described here as a 210 million partnership. The central public health purpose is to reduce new HIV infections among adolescent girls and young women in ten sub-Saharan African countries, including South Africa, by combining multiple proven interventions rather than relying on a single approach.
A key feature of DREAMS, as emphasized in the opportunity description, is that it goes beyond the health sector to address structural and social drivers that increase HIV vulnerability. The announcement highlights poverty, gender inequality, sexual violence, and lack of education as factors that directly or indirectly raise girls' risk of acquiring HIV. In practice, this framing signals that applicants would be expected to coordinate or deliver a layered package of interventions that connect biomedical prevention with social, educational, and protective services, rather than focusing narrowly on clinical activities alone.
Geographically, the work is targeted to five districts in South Africa: eThekwini, uMgungundlovu, and uMkhanyakude in KwaZulu-Natal, and the City of Johannesburg and Ekurhuleni in Gauteng. Across these five districts there are 31 sub-districts, with DREAMS focusing more intensively in 19 sub-districts identified as high burden and high transmission areas. This indicates the program is meant to concentrate resources where incidence and transmission risk are greatest, likely requiring strong local coordination and an ability to work at district and sub-district level with communities, schools, and families.
The opportunity lays out four main DREAMS objectives that guide the funded work: empowering girls and young women, mobilizing communities, strengthening families, and providing social protection. These objectives are presented as interconnected pillars aimed at improving overall life circumstances for adolescent girls and young women, with the expectation that these improvements translate into lower HIV risk. The announcement also links DREAMS outcomes to education and safety goals, specifically noting aims such as increased secondary school enrollment, attendance, and completion, along with reductions in violence and unintended pregnancy.
Finally, the funding announcement ties the program to clear prevention targets: reducing new HIV infections among 15-24 year old adolescent girls and young women by 25 percent by the end of 2016 and by 40 percent by the end of 2017. These targets reflect the initiative's focus on measurable incidence reduction over a relatively short timeline, implying an emphasis on rapid scale-up of evidence-based interventions, close monitoring of program performance, and strong implementation capacity in the selected districts. Eligible applicants are listed broadly as "Others" with additional eligibility details referenced elsewhere in the full notice, and the synopsis specifically names Epicentre Risk Management in the eligible applicant text, suggesting a narrowed or specialized eligibility context for this particular supplemental funding action.
Frequently Asked Questions (FAQs)
What is the official title of this grant opportunity?
The opportunity is titled "Support for Strengthening and Expanding HIV/AIDS Surveillance Activities in South Africa under PEPFAR."
What is the Funding Opportunity Number?
The Funding Opportunity Number is CDC RFA GH11-1154SUPP16.
Which U.S. agency is issuing this funding announcement?
This is a U.S. government discretionary funding announcement issued by the U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (HHS-CDC).
What type of funding mechanism is being used?
The funding instrument is a cooperative agreement. This typically means CDC expects substantial involvement in the work alongside the recipient, rather than providing funds with minimal ongoing federal participation.
What is the program and funding activity category?
The program falls under the health funding activity category.
What CFDA number is associated with this opportunity?
The opportunity is associated with CFDA 93.067.
When was the opportunity posted and when did it close?
The announcement was posted and created on January 8, 2016, and the application closing date was March 8, 2016.
How many awards are expected?
The notice indicates an expectation of one award.
Is there a published maximum award amount (award ceiling)?
The award ceiling is listed as 0 in the synopsis. This suggests the ceiling was not specified in the public summary and may instead be determined through budget negotiation and the cooperative agreement terms.
What major initiative is this announcement designed to support?
This announcement is designed to fund implementation of the DREAMS initiative, a major HIV prevention effort focused on adolescent girls and young women.
What does DREAMS stand for?
DREAMS stands for Determined, Resilient, Empowered, AIDS-free, Mentored, and Safe.
Who is the DREAMS initiative focused on?
The focus population is adolescent girls and young women ages 15 to 24.
What is the overarching public health purpose of DREAMS as described in the notice?
The stated purpose is to reduce new HIV infections among adolescent girls and young women in ten sub-Saharan African countries, including South Africa, by combining multiple proven interventions rather than relying on a single approach.
When and through what partnership was DREAMS launched?
DREAMS was launched through a partnership formed in 2015 among PEPFAR, the Bill and Melinda Gates Foundation, and the Nike Foundation, described in the notice as a 210 million partnership.
How does the notice describe DREAMS in terms of approach?
The notice emphasizes that DREAMS goes beyond the health sector and addresses structural and social drivers that increase HIV vulnerability, indicating an expectation of layered, multi-sector interventions.
What structural and social drivers of HIV risk are highlighted?
The announcement highlights poverty, gender inequality, sexual violence, and lack of education as factors that directly or indirectly increase girls' risk of acquiring HIV.
Where in South Africa is the work targeted?
The work is targeted to five districts in South Africa: eThekwini, uMgungundlovu, and uMkhanyakude in KwaZulu-Natal, and the City of Johannesburg and Ekurhuleni in Gauteng.
How many sub-districts are covered, and how many are prioritized for more intensive DREAMS focus?
Across the five districts there are 31 sub-districts, with DREAMS focusing more intensively in 19 sub-districts identified as high burden and high transmission areas.
What does the geographic targeting imply about implementation?
Based on the description, the program is intended to concentrate resources where HIV burden and transmission risk are highest, which implies the work would need to function effectively at district and sub-district levels and coordinate with local communities, schools, and families.
What are the four main DREAMS objectives listed in the announcement?
The four main objectives are: empowering girls and young women, mobilizing communities, strengthening families, and providing social protection.
How are the four DREAMS objectives described in relation to each other?
They are presented as interconnected pillars aimed at improving the overall life circumstances of adolescent girls and young women, with the expectation that these improvements translate into lower HIV risk.
What education and safety outcomes are mentioned?
The announcement notes aims such as increased secondary school enrollment, attendance, and completion, along with reductions in violence and unintended pregnancy.
What HIV prevention targets are specified and by when?
The notice ties the program to targets of reducing new HIV infections among 15-24 year old adolescent girls and young women by 25 percent by the end of 2016 and by 40 percent by the end of 2017.
What do these targets suggest about expectations for implementation and monitoring?
The short timeline and measurable incidence reduction goals suggest an emphasis on rapid scale-up of evidence-based interventions, close monitoring of program performance, and strong implementation capacity within the selected districts.
Who is eligible to apply based on the synopsis?
Eligible applicants are listed broadly as "Others," with additional eligibility details referenced elsewhere in the full notice.
Does the synopsis suggest any specialized or narrowed eligibility for this action?
Yes. The synopsis specifically names Epicentre Risk Management in the eligible applicant text, which suggests a narrowed or specialized eligibility context for this particular supplemental funding action.
Is this opportunity connected to PEPFAR?
Yes. The opportunity is explicitly described as supporting activities in South Africa under PEPFAR, and DREAMS is described as a major HIV prevention effort aligned with those goals.
Is the work limited to clinical or health-facility services?
The description indicates it is not limited to clinical services. DREAMS is framed as going beyond the health sector by addressing structural and social drivers, implying a broader package that may connect biomedical prevention with social, educational, and protective services.
Browse more opportunities from the same agency: HHS-CDC
Browse more opportunities from the same category: Health
Next opportunity: Alaska Native-Serving and Native Hawaiian-Serving Institutions Education Competitive Grants Program (ANNH)
Previous opportunity: Planning, Implementation and Evaluation of Comprehensive HIV Prevention Programs in the Republic of South Africa under PEPFAR
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA GH11 1154SUPP16
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA GH11 1154SUPP16) also looked into and applied for these:
| Funding Opportunity |
|---|
| The USAID Global Health Development Innovation Accelerator Broad Agency Announcement (BAA) Addendum 03 Apply for BAA GLOBALHEALTH 2016 Funding Number: BAA GLOBALHEALTH 2016 Agency: USAID Category: Health Funding Amount: Case Dependent |
| Centers for Disease Control and Prevention Reduce Hepatitis Infections by Treatment and Integrated Prevention Services (Hepatitis-TIPS) among Non-urban Young Persons Who Inject Drugs Apply for RFA PS 14 00403CONT16 Funding Number: RFA PS 14 00403CONT16 Agency: HHS-CDC-HHSCDCERA Category: Health Funding Amount: Case Dependent |
| NIDCR Small Research Grants for Data Analysis and Statistical Methodology Applied to Genome-wide Data (R03) Apply for PAR 16 070 Funding Number: PAR 16 070 Agency: HHS-NIH11 Category: Health Funding Amount: $200,000 |
| Establishment of a Strategic Partnership to Strengthen the South African National AIDS Council (SANAC) under PEPFAR Apply for CDC RFA GH13 1338SUPP16 Funding Number: CDC RFA GH13 1338SUPP16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| South African University-Based Technical Assistance aimed at Improving the Quality of HIV/AIDS and Related Services in SA under PEPFAR Apply for CDC RFA GH15 1574SUPP16 Funding Number: CDC RFA GH15 1574SUPP16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Support for Health System Strengthening of Leadership, Governance and Quality Improvement in the Ministry of Health (MOH) in the Kingdom of Swaziland under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1584CONT16 Funding Number: CDC RFA GH15 1584CONT16 Agency: HHS-CDC Category: Health Funding Amount: $685,000 |
| Comprehensive Facility-Based Technical Assistance in the Context of Health Systems Strengthening in South Africa under PEPFAR Apply for CDC RFA GH12 1257SUPP16 Funding Number: CDC RFA GH12 1257SUPP16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Secretary’s Minority AIDS Initiative Funding to Increase HIV Prevention and Care Service Delivery among Health Centers Serving High HIV Prevalence Jurisdictions Apply for CDC RFA PS14 141003CONT16 Funding Number: CDC RFA PS14 141003CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Sodium Reduction in Communities Apply for CDC RFA DP16 1607 Funding Number: CDC RFA DP16 1607 Agency: HHS-CDC-NCCDPHP Category: Health Funding Amount: $500,000 |
| Well Integrated Screening and Evaluation for Women Across the Nation (WISEWOMAN) Program Apply for CDC RFA DP13 130204CONT16 Funding Number: CDC RFA DP13 130204CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Building Ryan White HIV/AIDS Program Recipient Capacity to Engage People Living with HIV in Health Care Access Apply for HRSA 16 081 Funding Number: HRSA 16 081 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| Ryan White HIV/AIDS Part C Capacity Development Program Apply for HRSA 16 088 Funding Number: HRSA 16 088 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| State Public Health Approaches to Improving Arthritis Outcomes Apply for CDC RFA DP12 121005CONT16 Funding Number: CDC RFA DP12 121005CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| International Research Ethics Education and Curriculum Development Award (R25) Apply for PAR 16 081 Funding Number: PAR 16 081 Agency: HHS-NIH11 Category: Health Funding Amount: $230,000 |
| Cohort Study to Assess Population Impact of Current and Evolving Chronic Viral Hepatitis Treatment Apply for RFA PS 16 002 Funding Number: RFA PS 16 002 Agency: HHS-CDC-HHSCDCERA Category: Health Funding Amount: $500,000 |
| NIDCD National Human Ear Tissue Laboratory Resource for Hearing and Balance Research (U24) Apply for RFA DC 17 001 Funding Number: RFA DC 17 001 Agency: HHS-NIH11 Category: Health Funding Amount: $475,000 |
| 2016 Cooperative Agreements to Benefit Homeless Individuals (Short Title: CABHI) Apply for SM 16 007 Funding Number: SM 16 007 Agency: HHS-SAMHS Category: Health Funding Amount: $1,500,000 |
| State Public Health Actions to Prevent and Control Diabetes, Heart Disease, Obesity and Associated Risk Factors and Promote School Health Apply for CDC RFA DP13 130504CONT16 Funding Number: CDC RFA DP13 130504CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Ryan White HIV/AIDS Program Part F Dental Reimbursement Program Apply for HRSA 16 089 Funding Number: HRSA 16 089 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| Conducting Public Health Research in Kenya Apply for RFA GH 16 006 Funding Number: RFA GH 16 006 Agency: HHS-CDC-HHSCDCERA Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA GH11 1154SUPP16", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.